A Clinical Study of BT02 in Patients With Relapsed or Refractory Hematologic Malignancies

NCT07107204 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
NOT_YET_RECRUITING
Status
116
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Biotroy Therapeutics